[
  {
    "bcr_patient_uuid": "a43e5f0e-a21f-48d8-97e0-084d413680b7",
    "patient_ID": "TCGA.FA.8693",
    "bcr_drug_barcode": "TCGA-FA-8693-D42021",
    "bcr_drug_uuid": "135AF783-B37A-4F9F-A347-8BEACD26AFDC",
    "form_completion_date": "2013-4-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a43e5f0e-a21f-48d8-97e0-084d413680b7",
    "patient_ID": "TCGA.FA.8693",
    "bcr_drug_barcode": "TCGA-FA-8693-D42022",
    "bcr_drug_uuid": "D67B69A6-39D3-4F73-AE3E-83F14F085549",
    "form_completion_date": "2013-4-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a43e5f0e-a21f-48d8-97e0-084d413680b7",
    "patient_ID": "TCGA.FA.8693",
    "bcr_drug_barcode": "TCGA-FA-8693-D42023",
    "bcr_drug_uuid": "36E866F8-678B-4A70-B1CB-5C7DF42164E8",
    "form_completion_date": "2013-4-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1843C82E-7A35-474F-9F79-C0A9AF9AA09C",
    "patient_ID": "TCGA.FA.A4BB",
    "bcr_drug_barcode": "TCGA-FA-A4BB-D49913_4",
    "bcr_drug_uuid": "938A4D7C-3672-427A-BD49-FC36800DEE22",
    "form_completion_date": "2013-10-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CAV+BLEOMYCIN+ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "drug_cycles": 1,
    "drug_total_dose": 15,
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1843C82E-7A35-474F-9F79-C0A9AF9AA09C",
    "patient_ID": "TCGA.FA.A4BB",
    "bcr_drug_barcode": "TCGA-FA-A4BB-D49913",
    "bcr_drug_uuid": "4E93263A-FDB5-4CBD-9C4D-7F29200D2D2E",
    "form_completion_date": "2013-10-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CAV+BLEOMYCIN+ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 7000,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1843C82E-7A35-474F-9F79-C0A9AF9AA09C",
    "patient_ID": "TCGA.FA.A4BB",
    "bcr_drug_barcode": "TCGA-FA-A4BB-D49913_5",
    "bcr_drug_uuid": "182C40FA-682E-4B8C-B304-26E9A10E4296",
    "form_completion_date": "2013-10-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CAV+BLEOMYCIN+ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "drug_cycles": 1,
    "drug_total_dose": 600,
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1843C82E-7A35-474F-9F79-C0A9AF9AA09C",
    "patient_ID": "TCGA.FA.A4BB",
    "bcr_drug_barcode": "TCGA-FA-A4BB-D49913_2",
    "bcr_drug_uuid": "B74CFF30-97DF-42F1-9231-979AF9099E46",
    "form_completion_date": "2013-10-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CAV+BLEOMYCIN+ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 660,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1843C82E-7A35-474F-9F79-C0A9AF9AA09C",
    "patient_ID": "TCGA.FA.A4BB",
    "bcr_drug_barcode": "TCGA-FA-A4BB-D49913_3",
    "bcr_drug_uuid": "EEBB707E-22A0-4DEF-B850-A670AE829610",
    "form_completion_date": "2013-10-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CAV+BLEOMYCIN+ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 12,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF573AC-CD1E-42D8-90CF-B30D7B08679C",
    "patient_ID": "TCGA.FA.A6HN",
    "bcr_drug_barcode": "TCGA-FA-A6HN-D66290",
    "bcr_drug_uuid": "91152949-7D36-4C1D-81FE-544C726890CF",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 2,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 39,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF573AC-CD1E-42D8-90CF-B30D7B08679C",
    "patient_ID": "TCGA.FA.A6HN",
    "bcr_drug_barcode": "TCGA-FA-A6HN-D66290_4",
    "bcr_drug_uuid": "A86B2E06-F87E-47E2-86F4-BFB8F8365336",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 2,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 39,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF573AC-CD1E-42D8-90CF-B30D7B08679C",
    "patient_ID": "TCGA.FA.A6HN",
    "bcr_drug_barcode": "TCGA-FA-A6HN-D66290_2",
    "bcr_drug_uuid": "0029846C-393F-44F6-896C-4F46827BC793",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 2,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 39,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF573AC-CD1E-42D8-90CF-B30D7B08679C",
    "patient_ID": "TCGA.FA.A6HN",
    "bcr_drug_barcode": "TCGA-FA-A6HN-D66290_3",
    "bcr_drug_uuid": "220851B7-1300-403A-AE6A-DCFE04473A35",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 2,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 39,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69F23725-ADCA-48AC-9B33-80A7AAE24CFE",
    "patient_ID": "TCGA.FA.A6HO",
    "bcr_drug_barcode": "TCGA-FA-A6HO-D66292",
    "bcr_drug_uuid": "317B1D68-2D21-47C2-A415-35E3F10EDC3F",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 4,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69F23725-ADCA-48AC-9B33-80A7AAE24CFE",
    "patient_ID": "TCGA.FA.A6HO",
    "bcr_drug_barcode": "TCGA-FA-A6HO-D66292_4",
    "bcr_drug_uuid": "4EBA2B91-C735-4D8C-89DB-527AEBEE644B",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 4,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69F23725-ADCA-48AC-9B33-80A7AAE24CFE",
    "patient_ID": "TCGA.FA.A6HO",
    "bcr_drug_barcode": "TCGA-FA-A6HO-D66292_3",
    "bcr_drug_uuid": "08C2C6B9-73DD-4960-810C-9E6145FC5055",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 4,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69F23725-ADCA-48AC-9B33-80A7AAE24CFE",
    "patient_ID": "TCGA.FA.A6HO",
    "bcr_drug_barcode": "TCGA-FA-A6HO-D66292_2",
    "bcr_drug_uuid": "DF458224-02FA-4C78-8A97-AFAC8501C871",
    "form_completion_date": "2014-10-8",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 4,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ED746CB9-0F2F-48CE-923A-3A9F9F00B331",
    "patient_ID": "TCGA.FA.A7DS",
    "bcr_drug_barcode": "TCGA-FA-A7DS-D60938_3",
    "bcr_drug_uuid": "F2288912-FFF9-4274-AE36-521C23614A6E",
    "form_completion_date": "2014-6-19",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ED746CB9-0F2F-48CE-923A-3A9F9F00B331",
    "patient_ID": "TCGA.FA.A7DS",
    "bcr_drug_barcode": "TCGA-FA-A7DS-D60938_4",
    "bcr_drug_uuid": "5F62576D-4274-4208-85A3-8899C5A1B8B2",
    "form_completion_date": "2014-6-19",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ED746CB9-0F2F-48CE-923A-3A9F9F00B331",
    "patient_ID": "TCGA.FA.A7DS",
    "bcr_drug_barcode": "TCGA-FA-A7DS-D60938_2",
    "bcr_drug_uuid": "7B0AF303-FBCE-413A-A0B8-F96DFD3B6A66",
    "form_completion_date": "2014-6-19",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ED746CB9-0F2F-48CE-923A-3A9F9F00B331",
    "patient_ID": "TCGA.FA.A7DS",
    "bcr_drug_barcode": "TCGA-FA-A7DS-D60938",
    "bcr_drug_uuid": "9D1EF62D-747B-4A31-B776-48F95E359F79",
    "form_completion_date": "2014-6-19",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6365B38-BC44-400C-B4AA-18CE8FF5BFCE",
    "patient_ID": "TCGA.FA.A82F",
    "bcr_drug_barcode": "TCGA-FA-A82F-D65339",
    "bcr_drug_uuid": "73029286-B142-4EBE-814E-8957CA5FF6D7",
    "form_completion_date": "2014-9-22",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 4,
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6365B38-BC44-400C-B4AA-18CE8FF5BFCE",
    "patient_ID": "TCGA.FA.A82F",
    "bcr_drug_barcode": "TCGA-FA-A82F-D65339_2",
    "bcr_drug_uuid": "AE9E06CE-265A-4EAC-A8C7-71696F49A2FE",
    "form_completion_date": "2014-9-22",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 4,
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6365B38-BC44-400C-B4AA-18CE8FF5BFCE",
    "patient_ID": "TCGA.FA.A82F",
    "bcr_drug_barcode": "TCGA-FA-A82F-D65339_3",
    "bcr_drug_uuid": "CCA80706-08AA-412B-A691-BEF802B2EB64",
    "form_completion_date": "2014-9-22",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 4,
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6365B38-BC44-400C-B4AA-18CE8FF5BFCE",
    "patient_ID": "TCGA.FA.A82F",
    "bcr_drug_barcode": "TCGA-FA-A82F-D65339_4",
    "bcr_drug_uuid": "B8359E07-B573-420A-A23C-F533866789A3",
    "form_completion_date": "2014-9-22",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 4,
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71026",
    "bcr_drug_uuid": "DEC3D8EC-9F8A-4CC4-8902-D0CC9FB6ACA6",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "ABOD",
    "pharmaceutical_therapy_drug_name": "DACARBAZINE",
    "drug_cycles": 4,
    "drug_total_dose": 4800,
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71026_4",
    "bcr_drug_uuid": "A137FA56-0287-4BBF-A058-6B814D6DEDAD",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "ABOD",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 4,
    "drug_total_dose": 360,
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71026_2",
    "bcr_drug_uuid": "AB46B6EB-1B37-43E0-B3D6-985A04CBD43B",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "ABOD",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "drug_cycles": 4,
    "drug_total_dose": 60,
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71026_3",
    "bcr_drug_uuid": "8BCAEB28-AAE8-4C80-BEC9-0D4CE14608CB",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "ABOD",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 4,
    "drug_total_dose": 8,
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71024",
    "bcr_drug_uuid": "DE8A4FBB-08F7-4C6D-930F-C1934E0B43D4",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CNV",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 1,
    "drug_total_dose": 1000,
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71024_3",
    "bcr_drug_uuid": "1216F129-6E40-4F89-B8AC-A1A2E307756E",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CNV",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "drug_cycles": 1,
    "drug_total_dose": 400,
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71024_2",
    "bcr_drug_uuid": "27066BBA-B9D8-457E-A6B6-DD07B69B0EFE",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CNV",
    "pharmaceutical_therapy_drug_name": "MITOXANTRONE",
    "drug_cycles": 1,
    "drug_total_dose": 16,
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71025_4",
    "bcr_drug_uuid": "3C09E707-956E-48CF-94CE-58119DE34B46",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP + ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "drug_cycles": 2,
    "drug_total_dose": 800,
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71025",
    "bcr_drug_uuid": "4B9A65E4-A2F2-4717-9316-8CCD03041492",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP + ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 2,
    "drug_total_dose": 2400,
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71025_2",
    "bcr_drug_uuid": "06CF0922-2479-4CE8-8E50-0E31C537746D",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP + ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 2,
    "drug_total_dose": 160,
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71025_5",
    "bcr_drug_uuid": "86658E32-5C86-4202-B61F-52F44043BCE2",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP + ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "drug_cycles": 2,
    "drug_total_dose": 36,
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B56BDBDB-43AF-4A03-A072-54DD22D7550C",
    "patient_ID": "TCGA.FA.A86F",
    "bcr_drug_barcode": "TCGA-FA-A86F-D71025_3",
    "bcr_drug_uuid": "8FFDF0DC-B03B-4F3D-9700-47E09B11FBE6",
    "form_completion_date": "2015-3-13",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP + ETOPOSIDE",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 2,
    "drug_total_dose": 4,
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f971af1-6772-4fe6-8d35-bbe527a037fe",
    "patient_ID": "TCGA.FF.8041",
    "bcr_drug_barcode": "TCGA-FF-8041-D30779_2",
    "bcr_drug_uuid": "DFFE9DAE-80BA-434F-A658-727A655F0D78",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "EPOCH-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3600,
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f971af1-6772-4fe6-8d35-bbe527a037fe",
    "patient_ID": "TCGA.FF.8041",
    "bcr_drug_barcode": "TCGA-FF-8041-D30779",
    "bcr_drug_uuid": "D65F998A-9E3F-499F-B32E-93A9DF1BBF69",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "EPOCH-R",
    "pharmaceutical_therapy_drug_name": "EPOCH",
    "drug_cycles": 6,
    "drug_total_dose": 11037,
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0a326d2-1f3e-4a5d-bca8-32aaccc52338",
    "patient_ID": "TCGA.FF.8042",
    "bcr_drug_barcode": "TCGA-FF-8042-D30772_2",
    "bcr_drug_uuid": "179A1EE3-8D69-4D5C-A128-3C355271CC97",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3600,
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0a326d2-1f3e-4a5d-bca8-32aaccc52338",
    "patient_ID": "TCGA.FF.8042",
    "bcr_drug_barcode": "TCGA-FF-8042-D30772",
    "bcr_drug_uuid": "428B6555-9B90-45F4-ACC7-A9E537D2E517",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "CHOP",
    "drug_cycles": 6,
    "drug_total_dose": 7958.4,
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8e2df1e-4042-42af-9231-3a00e83489f0",
    "patient_ID": "TCGA.FF.8043",
    "bcr_drug_barcode": "TCGA-FF-8043-D30760",
    "bcr_drug_uuid": "1DFC396F-60E8-4614-8155-F4028B370DEB",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R, EPOCH-R",
    "pharmaceutical_therapy_drug_name": "CHOP",
    "drug_cycles": 1,
    "drug_total_dose": 1126.4,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8e2df1e-4042-42af-9231-3a00e83489f0",
    "patient_ID": "TCGA.FF.8043",
    "bcr_drug_barcode": "TCGA-FF-8043-D30760_2",
    "bcr_drug_uuid": "2E28A4D0-22CD-4DD4-92A0-997D1E91BAF2",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R, EPOCH-R",
    "pharmaceutical_therapy_drug_name": "EPOCH",
    "drug_cycles": 5,
    "drug_total_dose": 11089.4,
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8e2df1e-4042-42af-9231-3a00e83489f0",
    "patient_ID": "TCGA.FF.8043",
    "bcr_drug_barcode": "TCGA-FF-8043-D30760_3",
    "bcr_drug_uuid": "1CA0D934-520F-4803-AE7B-0FEAFAD29EDA",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R, EPOCH-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3600,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67325322-483f-443f-9ffa-2a20d108a2fb",
    "patient_ID": "TCGA.FF.8046",
    "bcr_drug_barcode": "TCGA-FF-8046-D30763_2",
    "bcr_drug_uuid": "E75F7D2F-B334-476E-8C99-D6310F639889",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 800,
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67325322-483f-443f-9ffa-2a20d108a2fb",
    "patient_ID": "TCGA.FF.8046",
    "bcr_drug_barcode": "TCGA-FF-8046-D30763",
    "bcr_drug_uuid": "7A3ACC7E-B1C7-4C82-A5D8-9F4A48075D44",
    "form_completion_date": "2011-12-14",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "CHOP",
    "drug_cycles": 6,
    "drug_total_dose": 7358.4,
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f978cb0f-d319-4c01-b4c5-23ae1403a106",
    "patient_ID": "TCGA.FF.8047",
    "bcr_drug_barcode": "TCGA-FF-8047-D30871",
    "bcr_drug_uuid": "F729AC87-439D-452F-B2A8-7311B26ED606",
    "form_completion_date": "2012-1-5",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "HYPERCVAD",
    "pharmaceutical_therapy_drug_name": "O-ICE",
    "drug_cycles": 2,
    "drug_total_dose": 4574.05,
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "f978cb0f-d319-4c01-b4c5-23ae1403a106",
    "patient_ID": "TCGA.FF.8047",
    "bcr_drug_barcode": "TCGA-FF-8047-D30916_2",
    "bcr_drug_uuid": "13F1B589-73B8-4F8E-8D2A-7538F7F03858",
    "form_completion_date": "2012-1-5",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "O-ICE",
    "pharmaceutical_therapy_drug_name": "OFATUMUMAB",
    "drug_cycles": 2,
    "drug_total_dose": 2000,
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "f978cb0f-d319-4c01-b4c5-23ae1403a106",
    "patient_ID": "TCGA.FF.8047",
    "bcr_drug_barcode": "TCGA-FF-8047-D30871_2",
    "bcr_drug_uuid": "E445A599-E0A1-41D5-8C34-1F438B20AF16",
    "form_completion_date": "2012-1-5",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "HYPERCVAD",
    "pharmaceutical_therapy_drug_name": "CVAD",
    "drug_cycles": 1,
    "drug_total_dose": 9,
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "f978cb0f-d319-4c01-b4c5-23ae1403a106",
    "patient_ID": "TCGA.FF.8047",
    "bcr_drug_barcode": "TCGA-FF-8047-D30916",
    "bcr_drug_uuid": "E05BBA28-53CE-4934-AF70-51B33588BA2F",
    "form_completion_date": "2012-1-5",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "O-ICE",
    "pharmaceutical_therapy_drug_name": "ICE",
    "drug_cycles": 2,
    "drug_total_dose": 2574.05,
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "c8cde9ea-89e9-4ee8-8a46-417a48f6d3ab",
    "patient_ID": "TCGA.FF.8061",
    "bcr_drug_barcode": "TCGA-FF-8061-D30767",
    "bcr_drug_uuid": "D0130D61-8607-4A5A-9A50-8BCEE8F3DC72",
    "form_completion_date": "2012-1-17",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "EPOCH-R",
    "pharmaceutical_therapy_drug_name": "EPOCH",
    "drug_cycles": 6,
    "drug_total_dose": 11235.6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c8cde9ea-89e9-4ee8-8a46-417a48f6d3ab",
    "patient_ID": "TCGA.FF.8061",
    "bcr_drug_barcode": "TCGA-FF-8061-D30767_2",
    "bcr_drug_uuid": "B4D34140-DBC3-4842-82DE-A08923A9F606",
    "form_completion_date": "2012-1-17",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "EPOCH-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 600,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0e9fcccc-0630-408d-a121-2c6413824cb7",
    "patient_ID": "TCGA.FF.8062",
    "bcr_drug_barcode": "TCGA-FF-8062-D30775_2",
    "bcr_drug_uuid": "024DC550-61E5-4372-983E-456BEBE7E901",
    "form_completion_date": "2012-1-17",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3600,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0e9fcccc-0630-408d-a121-2c6413824cb7",
    "patient_ID": "TCGA.FF.8062",
    "bcr_drug_barcode": "TCGA-FF-8062-D30775",
    "bcr_drug_uuid": "E39BFE49-7576-4E71-B7B6-BCDA7FC1AE2A",
    "form_completion_date": "2012-1-17",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-R",
    "pharmaceutical_therapy_drug_name": "CHOP",
    "drug_cycles": 6,
    "drug_total_dose": 7358.4,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_4",
    "bcr_drug_uuid": "52623733-5961-45BB-B830-052BD44DC492",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "ONCOVIN",
    "drug_cycles": 5,
    "drug_total_dose": 6,
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_2",
    "bcr_drug_uuid": "92EAFF92-E8FC-4178-BCF6-6CC02C215FD0",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 5,
    "drug_total_dose": 5435,
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_7",
    "bcr_drug_uuid": "601719FD-10F4-45DF-808E-D02FF6B25905",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 1,
    "drug_total_dose": 1050,
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_9",
    "bcr_drug_uuid": "DAB14F1D-9C01-4B9C-A7E8-A28839149D9A",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 1,
    "drug_total_dose": 50,
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788",
    "bcr_drug_uuid": "80B129DF-FC3C-4B46-B6E3-F213C36E07A0",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 5,
    "drug_total_dose": 2900,
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_6",
    "bcr_drug_uuid": "9274A82B-C53E-4422-A465-08567262E2B0",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 1,
    "drug_total_dose": 600,
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_3",
    "bcr_drug_uuid": "1BBB9C67-B349-4E8D-A0AB-375D33F0AF62",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "HYDROXYDAUNOMYCIN",
    "drug_cycles": 5,
    "drug_total_dose": 315,
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_5",
    "bcr_drug_uuid": "C9035AA0-EFB5-4B40-8B97-6176543769F8",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 5,
    "drug_total_dose": 250,
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F553F1A9-ECF2-4783-A609-6ADCA7C4C597",
    "patient_ID": "TCGA.FF.A7CQ",
    "bcr_drug_barcode": "TCGA-FF-A7CQ-D50788_8",
    "bcr_drug_uuid": "FBA2DD7D-65DD-4070-BE68-8FE1D0559A65",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, R-CVP",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 1,
    "drug_total_dose": 0,
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794_3",
    "bcr_drug_uuid": "772AFB9A-778C-42E7-A70B-5600CBC7DACA",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "HYDROXYDAUNOMYCIN",
    "drug_cycles": 5,
    "drug_total_dose": 315,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794",
    "bcr_drug_uuid": "3042F2C8-F2C0-4E47-965B-30DE11130DA5",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 5,
    "drug_total_dose": 3500,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794_2",
    "bcr_drug_uuid": "8710C7EF-BC9A-4500-AAB4-783693309F92",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 5,
    "drug_total_dose": 5435,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794_6",
    "bcr_drug_uuid": "84114107-A7A3-474E-9044-119C058FEEEA",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "drug_cycles": 2,
    "drug_total_dose": 154,
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794_5",
    "bcr_drug_uuid": "EB5BD415-6C20-42C4-BCD5-66DD2E4D1576",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 5,
    "drug_total_dose": 250,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F784BC3A-751B-4025-AAB2-0AF2F6F24266",
    "patient_ID": "TCGA.FF.A7CR",
    "bcr_drug_barcode": "TCGA-FF-A7CR-D50794_4",
    "bcr_drug_uuid": "A00B1979-3777-428B-A0AF-34E8C1D9C1DB",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, METHOTREXATE",
    "pharmaceutical_therapy_drug_name": "ONCOVIN",
    "drug_cycles": 5,
    "drug_total_dose": 6,
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D0DB5D7-39CA-466D-96B3-0D278C5EA768",
    "patient_ID": "TCGA.FF.A7CW",
    "bcr_drug_barcode": "TCGA-FF-A7CW-D50792_3",
    "bcr_drug_uuid": "0228B3C5-C324-4B66-86BB-AC58536457B7",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP",
    "pharmaceutical_therapy_drug_name": "HYDROXYDAUNOMYCIN",
    "drug_cycles": 6,
    "drug_total_dose": 330,
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D0DB5D7-39CA-466D-96B3-0D278C5EA768",
    "patient_ID": "TCGA.FF.A7CW",
    "bcr_drug_barcode": "TCGA-FF-A7CW-D50792_4",
    "bcr_drug_uuid": "EA7245ED-73C2-46DA-970D-A58AC452E2E0",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP",
    "pharmaceutical_therapy_drug_name": "ONCOVIN",
    "drug_cycles": 6,
    "drug_total_dose": 9,
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D0DB5D7-39CA-466D-96B3-0D278C5EA768",
    "patient_ID": "TCGA.FF.A7CW",
    "bcr_drug_barcode": "TCGA-FF-A7CW-D50792",
    "bcr_drug_uuid": "2E2BC6FD-0193-49BA-BE46-635C02C61828",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3600,
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D0DB5D7-39CA-466D-96B3-0D278C5EA768",
    "patient_ID": "TCGA.FF.A7CW",
    "bcr_drug_barcode": "TCGA-FF-A7CW-D50792_5",
    "bcr_drug_uuid": "E8394FA4-26C0-4B02-B63E-8E19DF8C7F31",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 6,
    "drug_total_dose": 300,
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D0DB5D7-39CA-466D-96B3-0D278C5EA768",
    "patient_ID": "TCGA.FF.A7CW",
    "bcr_drug_barcode": "TCGA-FF-A7CW-D50792_2",
    "bcr_drug_uuid": "BF2C5E4A-200F-4F18-A82A-520656E6316A",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 4800,
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790_6",
    "bcr_drug_uuid": "EAF62F38-A175-4CCC-A171-8F4AD67B5080",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "drug_cycles": 6,
    "drug_total_dose": 462,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790",
    "bcr_drug_uuid": "56104C2E-9F5A-4DA4-86D7-D7ADF88FA792",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 7,
    "drug_total_dose": 4200,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790_4",
    "bcr_drug_uuid": "74B01D6C-EDD2-4708-895A-4272C50364C9",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "ONCOVIN",
    "drug_cycles": 7,
    "drug_total_dose": 6,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790_2",
    "bcr_drug_uuid": "A21BA3B0-4111-4909-A5D7-5FA3FE803E0F",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 7,
    "drug_total_dose": 7535,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790_5",
    "bcr_drug_uuid": "2DBC5B80-3E53-41A9-A109-285E21829469",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "PREDNISOLONE",
    "drug_cycles": 7,
    "drug_total_dose": 350,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29E3D122-15A1-4235-A356-B1A9F94CEB39",
    "patient_ID": "TCGA.FF.A7CX",
    "bcr_drug_barcode": "TCGA-FF-A7CX-D50790_3",
    "bcr_drug_uuid": "410727FB-5FD4-4E7C-BDD5-59BE95B2F35C",
    "form_completion_date": "2013-10-30",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "R-CHOP, IT-MTX",
    "pharmaceutical_therapy_drug_name": "HYDROXYDAUNOMYCIN",
    "drug_cycles": 7,
    "drug_total_dose": 415,
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe",
    "patient_ID": "TCGA.FM.8000",
    "bcr_drug_barcode": "TCGA-FM-8000-D64271_2",
    "bcr_drug_uuid": "C5452F91-9869-4D62-B03D-8E73F1FBD703",
    "form_completion_date": "2014-8-28",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VAC + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 6,
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe",
    "patient_ID": "TCGA.FM.8000",
    "bcr_drug_barcode": "TCGA-FM-8000-D64271_4",
    "bcr_drug_uuid": "447096F6-02F3-4186-8F4D-778D694D852D",
    "form_completion_date": "2014-8-28",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VAC + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe",
    "patient_ID": "TCGA.FM.8000",
    "bcr_drug_barcode": "TCGA-FM-8000-D64271_3",
    "bcr_drug_uuid": "95EC61B8-76F9-4C3F-AAE4-B8E04EB3362D",
    "form_completion_date": "2014-8-28",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VAC + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "drug_cycles": 6,
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe",
    "patient_ID": "TCGA.FM.8000",
    "bcr_drug_barcode": "TCGA-FM-8000-D64271",
    "bcr_drug_uuid": "08249E2D-A967-40E1-9B6A-2C8351DB72DF",
    "form_completion_date": "2014-8-28",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VAC + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34191",
    "bcr_drug_uuid": "EDD8D7F4-4776-4C99-968D-3A92F9F53A1A",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 7440,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34191_2",
    "bcr_drug_uuid": "8629D630-E55B-493A-8F30-9520E029640D",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 486,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34191_4",
    "bcr_drug_uuid": "0F1E2ACB-15D3-4B7A-BCB3-3C1410D0559A",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 3720,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34191_3",
    "bcr_drug_uuid": "1AED32E7-03AA-427D-9D4F-6356FF387D01",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 12,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34289",
    "bcr_drug_uuid": "92030E61-DC07-48AE-8B69-2FB4EA4C4993",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "drug_cycles": 1,
    "drug_total_dose": 250,
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 394,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34289_3",
    "bcr_drug_uuid": "1B7DD8BE-B615-4ADF-B13E-96F37BC60CAA",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "drug_cycles": 1,
    "drug_total_dose": 400,
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 394,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34289_2",
    "bcr_drug_uuid": "6F7FFA58-77D9-444D-8CCB-47D9F65189DE",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC",
    "pharmaceutical_therapy_drug_name": "CYTARABINE",
    "drug_cycles": 1,
    "drug_total_dose": 20000,
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 394,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34289_4",
    "bcr_drug_uuid": "3E3B0DE9-0543-4202-8F14-4A321A6593B1",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC",
    "pharmaceutical_therapy_drug_name": "DECADRON",
    "drug_cycles": 1,
    "drug_total_dose": 250,
    "days_to_drug_start": 390,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 394,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34294_3",
    "bcr_drug_uuid": "3494688B-F893-493D-9939-29166EE1F6E5",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "BORTEZOMIB, RITUXIMAB, DOXORUBICIN",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "days_to_drug_start": 971,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1124,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34294",
    "bcr_drug_uuid": "D9C5CE61-C566-4838-87A9-4AFD9113E25C",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "BORTEZOMIB, RITUXIMAB, DOXORUBICIN",
    "pharmaceutical_therapy_drug_name": "BORTEZOMIB",
    "days_to_drug_start": 971,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1124,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34294_2",
    "bcr_drug_uuid": "08059BFB-1A20-4B74-AC58-6A85BF59D20B",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "BORTEZOMIB, RITUXIMAB, DOXORUBICIN",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "days_to_drug_start": 971,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1124,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34296",
    "bcr_drug_uuid": "BE39CF08-F248-4FC7-B4F3-63D5C09073DF",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "RITUXIMAB, GEMCITABINE, NAVELBINE",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 2,
    "drug_total_dose": 1230,
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1200,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34296_2",
    "bcr_drug_uuid": "E5EAB346-2F37-4EE4-B4E1-FA2DE410EBF9",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "RITUXIMAB, GEMCITABINE, NAVELBINE",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "drug_cycles": 2,
    "drug_total_dose": 66,
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1200,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34296_3",
    "bcr_drug_uuid": "35FE73B5-55A4-4221-B8EE-51A3860E5643",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "RITUXIMAB, GEMCITABINE, NAVELBINE",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "drug_cycles": 2,
    "drug_total_dose": 3300,
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1200,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6a21c948-cd85-4150-8c01-83017d7dc1ed",
    "patient_ID": "TCGA.G8.6324",
    "bcr_drug_barcode": "TCGA-G8-6324-D34297",
    "bcr_drug_uuid": "B2FA6499-B88F-4757-9B9A-8254D16843E7",
    "form_completion_date": "2012-8-7",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 501,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "REVLIMID",
    "days_to_drug_start": 1148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ea54dbad-1b23-41cc-9378-d4002a8fca51",
    "patient_ID": "TCGA.G8.6325",
    "bcr_drug_barcode": "TCGA-G8-6325-D40598",
    "bcr_drug_uuid": "9134192D-2B36-4B84-82BD-AF688A65DB03",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ea54dbad-1b23-41cc-9378-d4002a8fca51",
    "patient_ID": "TCGA.G8.6325",
    "bcr_drug_barcode": "TCGA-G8-6325-D40598_4",
    "bcr_drug_uuid": "0F6EA0BA-440B-4D12-B2F0-27EE1D33F6A5",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ea54dbad-1b23-41cc-9378-d4002a8fca51",
    "patient_ID": "TCGA.G8.6325",
    "bcr_drug_barcode": "TCGA-G8-6325-D40598_2",
    "bcr_drug_uuid": "8F378C65-C037-47C3-849B-5A582E953590",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ea54dbad-1b23-41cc-9378-d4002a8fca51",
    "patient_ID": "TCGA.G8.6325",
    "bcr_drug_barcode": "TCGA-G8-6325-D40598_3",
    "bcr_drug_uuid": "F848B469-BA1B-439C-A8DC-37B0AAAFBF1B",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40596",
    "bcr_drug_uuid": "45166991-FDF0-4624-A8EC-312618E3DBC1",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40596_2",
    "bcr_drug_uuid": "0F992B2F-F033-4676-A5F8-96B6BAC3A3FD",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40596_3",
    "bcr_drug_uuid": "AD8376AE-215D-4C7C-ACD4-79117B2CE2BA",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40596_4",
    "bcr_drug_uuid": "01709570-A5EB-4AA4-81C7-585CBAC2A91D",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-14 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40597_3",
    "bcr_drug_uuid": "48374163-46DD-4FA7-8C01-0E0CC2E721FE",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC-RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYTARABINE",
    "drug_cycles": 2,
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 297,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40597",
    "bcr_drug_uuid": "8A4DA5D0-4DCA-4A04-B34C-A7C12CD9A4BD",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC-RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 2,
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 297,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40597_4",
    "bcr_drug_uuid": "CFA0D6B9-96C8-461D-AE1C-93B6090F9F1B",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC-RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "drug_cycles": 2,
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 297,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f8cf647b-1447-4ac3-8c43-bef07765cabf",
    "patient_ID": "TCGA.G8.6326",
    "bcr_drug_barcode": "TCGA-G8-6326-D40597_2",
    "bcr_drug_uuid": "0B524C94-8920-4F3F-A093-B686F073E3D3",
    "form_completion_date": "2013-2-25",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC-RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "drug_cycles": 2,
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 297,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32210",
    "bcr_drug_uuid": "FA9B3DC4-8BFE-440D-80E7-5A687790767B",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "drug_total_dose": 360,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32211",
    "bcr_drug_uuid": "79242EFE-45B5-447C-991D-A7B9821ED5C3",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CVP + BLEOMYCIN",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "days_to_drug_start": 1257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32211_3",
    "bcr_drug_uuid": "4BB8A0F9-0165-4CE6-96F2-56CDBEE69D72",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CVP + BLEOMYCIN",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "days_to_drug_start": 1257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32212_2",
    "bcr_drug_uuid": "2F22A9D3-46EA-4901-8BEA-016C8EEEFBA3",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 2656,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VP-16 + CYTOXAN",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "days_to_drug_start": 2561,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2564,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32210_3",
    "bcr_drug_uuid": "59298DFE-9669-49BC-A3CA-AEC2E555CCB6",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "drug_cycles": 6,
    "drug_total_dose": 9000,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32213",
    "bcr_drug_uuid": "0D4E2501-8534-445E-B61B-22821485CBAE",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 2656,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "THIOTEPA",
    "days_to_drug_start": 2643,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32210_2",
    "bcr_drug_uuid": "C1F3E7F3-FAF1-42F4-A5F8-E4D263CC66FE",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 12,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32211_2",
    "bcr_drug_uuid": "CBC23B49-86D4-4E6F-A117-9ED8F31E7E5B",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CVP + BLEOMYCIN",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "days_to_drug_start": 1257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32213_2",
    "bcr_drug_uuid": "C255DE4E-7123-4236-9734-EA22DF186135",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 2656,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "SINGLE AGENT THERAPY (PLEASE SPECIFY)",
    "pharmaceutical_therapy_drug_name": "IL-2",
    "days_to_drug_start": 2930,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2988,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3f5a897d-1eaa-4d4c-8324-27ac07c90927",
    "patient_ID": "TCGA.G8.6906",
    "bcr_drug_barcode": "TCGA-G8-6906-D32212",
    "bcr_drug_uuid": "40AAFE2E-9046-4501-9A43-F29107E34F6D",
    "form_completion_date": "2012-5-16",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 2656,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "VP-16 + CYTOXAN",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "days_to_drug_start": 2561,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2564,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32159_3",
    "bcr_drug_uuid": "5B8D45E7-7FC1-4CF5-B51A-5A2DB147011F",
    "form_completion_date": "2012-5-17",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 386,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC + RITUXAN",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "drug_cycles": 2,
    "days_to_drug_start": 288,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32159",
    "bcr_drug_uuid": "CCD19362-5CAF-41D6-9875-3028265817EB",
    "form_completion_date": "2012-5-17",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 386,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC + RITUXAN",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "drug_cycles": 2,
    "days_to_drug_start": 288,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32159_2",
    "bcr_drug_uuid": "595AADBD-4058-4F7B-974B-8BA389B76EBD",
    "form_completion_date": "2012-5-17",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 386,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC + RITUXAN",
    "pharmaceutical_therapy_drug_name": "HIGH DOSE ARA-C",
    "drug_cycles": 2,
    "days_to_drug_start": 288,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32159_4",
    "bcr_drug_uuid": "DA2E74AF-FDCC-4341-BEDD-8CDD0386C809",
    "form_completion_date": "2012-5-17",
    "stem_cell_transplantation": true,
    "stem_cell_transplantation_type": "AUTOLOGOUS",
    "days_to_stem_cell_transplantation": 386,
    "therapy_regimen": "PROGRESSION",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "DHAC + RITUXAN",
    "pharmaceutical_therapy_drug_name": "RITUXAN",
    "drug_cycles": 2,
    "days_to_drug_start": 288,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32151_3",
    "bcr_drug_uuid": "BF797055-A2C0-4C06-AAF6-9CC842CCC04B",
    "form_completion_date": "2012-5-18",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 8,
    "drug_total_dose": 800,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32151_4",
    "bcr_drug_uuid": "F36F9349-F61C-4890-9623-26FF73DDACFF",
    "form_completion_date": "2012-5-18",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 8,
    "drug_total_dose": 12120,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32151_2",
    "bcr_drug_uuid": "9560CDC5-286F-488D-A4AD-CD5BB13C1D26",
    "form_completion_date": "2012-5-18",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 8,
    "drug_total_dose": 16,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31bbad4e-3789-42ec-9faa-1cb86970f723",
    "patient_ID": "TCGA.G8.6907",
    "bcr_drug_barcode": "TCGA-G8-6907-D32151",
    "bcr_drug_uuid": "0B8697E1-5ADC-4A1A-B7EF-1EFA7EFAFDC2",
    "form_completion_date": "2012-5-18",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP- NOT SPECIFIED",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 8,
    "drug_total_dose": 800,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063_6",
    "bcr_drug_uuid": "3FF96B44-C2DD-408D-8CB7-3296BBB640DA",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063_2",
    "bcr_drug_uuid": "7E6B74B7-2B6E-464C-8EDA-744AE2C28B52",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063_3",
    "bcr_drug_uuid": "67D1B60D-70F4-492A-A772-EA23F163D085",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063",
    "bcr_drug_uuid": "874E3DA2-0B4F-41DB-A6D2-3356BA1B2912",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063_4",
    "bcr_drug_uuid": "EB5C0F58-229F-42E0-B764-DC3A439CEBA7",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a468e725-ad4b-411d-ac5c-2eacc68ec580",
    "patient_ID": "TCGA.G8.6909",
    "bcr_drug_barcode": "TCGA-G8-6909-D43063_5",
    "bcr_drug_uuid": "CAC0013D-F449-4201-AFDD-35BA7DA345E0",
    "form_completion_date": "2013-5-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "OTHER PHARMACEUTICAL REGIMEN (PLEASE SPECIFY)",
    "pharm_regimen_other": "CHOP-21 + RITUXIMAB + DOXIL",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "drug_cycles": 6,
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3622cf29-600f-4410-84d4-a9afeb41c475",
    "patient_ID": "TCGA.G8.6914",
    "bcr_drug_barcode": "TCGA-G8-6914-D43066_4",
    "bcr_drug_uuid": "E08AED2A-D148-4E4F-9E7E-768D2A80064E",
    "form_completion_date": "2013-5-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3622cf29-600f-4410-84d4-a9afeb41c475",
    "patient_ID": "TCGA.G8.6914",
    "bcr_drug_barcode": "TCGA-G8-6914-D43066_3",
    "bcr_drug_uuid": "F45A354E-E356-435B-83FD-DE3452AB3CC5",
    "form_completion_date": "2013-5-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3622cf29-600f-4410-84d4-a9afeb41c475",
    "patient_ID": "TCGA.G8.6914",
    "bcr_drug_barcode": "TCGA-G8-6914-D43066",
    "bcr_drug_uuid": "62337BE0-7E6A-4061-AA58-D004BE069564",
    "form_completion_date": "2013-5-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "drug_cycles": 6,
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3622cf29-600f-4410-84d4-a9afeb41c475",
    "patient_ID": "TCGA.G8.6914",
    "bcr_drug_barcode": "TCGA-G8-6914-D43066_2",
    "bcr_drug_uuid": "FC006124-E614-4FFC-B843-B296612B6EF3",
    "form_completion_date": "2013-5-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "drug_cycles": 6,
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a589441-11ef-4158-87e7-3951d86bc2aa",
    "patient_ID": "TCGA.GR.7351",
    "bcr_drug_barcode": "TCGA-GR-7351-D33374_2",
    "bcr_drug_uuid": "49C50BB6-4C14-4521-AEE8-43784519316A",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 4,
    "drug_total_dose": 92,
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a589441-11ef-4158-87e7-3951d86bc2aa",
    "patient_ID": "TCGA.GR.7351",
    "bcr_drug_barcode": "TCGA-GR-7351-D33374_3",
    "bcr_drug_uuid": "62C11300-7678-43BA-8939-41AF9F6A7F17",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 4,
    "drug_total_dose": 2,
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a589441-11ef-4158-87e7-3951d86bc2aa",
    "patient_ID": "TCGA.GR.7351",
    "bcr_drug_barcode": "TCGA-GR-7351-D33374_5",
    "bcr_drug_uuid": "F7EFD1E7-6135-432F-A849-74F2C4763479",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 4,
    "drug_total_dose": 686,
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a589441-11ef-4158-87e7-3951d86bc2aa",
    "patient_ID": "TCGA.GR.7351",
    "bcr_drug_barcode": "TCGA-GR-7351-D33374",
    "bcr_drug_uuid": "E75F69EB-26AC-4DB4-9827-6F60E9A274BE",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 4,
    "drug_total_dose": 1375,
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7a589441-11ef-4158-87e7-3951d86bc2aa",
    "patient_ID": "TCGA.GR.7351",
    "bcr_drug_barcode": "TCGA-GR-7351-D33374_4",
    "bcr_drug_uuid": "3B1EB05B-E8D5-467F-AC4C-AEEE50AB4AF6",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 4,
    "drug_total_dose": 500,
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c3d662ee-48d0-454a-bb0c-77d3338d3747",
    "patient_ID": "TCGA.GR.7353",
    "bcr_drug_barcode": "TCGA-GR-7353-D33443_2",
    "bcr_drug_uuid": "9F2E2434-0FA7-45DA-8116-3DE01627B782",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 90,
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c3d662ee-48d0-454a-bb0c-77d3338d3747",
    "patient_ID": "TCGA.GR.7353",
    "bcr_drug_barcode": "TCGA-GR-7353-D33443",
    "bcr_drug_uuid": "9B77ED7C-2BE1-423E-93CE-8236B9894149",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 1350,
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c3d662ee-48d0-454a-bb0c-77d3338d3747",
    "patient_ID": "TCGA.GR.7353",
    "bcr_drug_barcode": "TCGA-GR-7353-D33443_3",
    "bcr_drug_uuid": "5B1F1B53-9833-46AF-B172-D65AC7480DE9",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 2,
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c3d662ee-48d0-454a-bb0c-77d3338d3747",
    "patient_ID": "TCGA.GR.7353",
    "bcr_drug_barcode": "TCGA-GR-7353-D33443_5",
    "bcr_drug_uuid": "0C2DD57D-D9F9-42DD-BFE5-17AB08691D89",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 675,
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c3d662ee-48d0-454a-bb0c-77d3338d3747",
    "patient_ID": "TCGA.GR.7353",
    "bcr_drug_barcode": "TCGA-GR-7353-D33443_4",
    "bcr_drug_uuid": "42B8F78E-BC6A-4E4B-BEE7-5199E7CF843F",
    "form_completion_date": "2012-7-3",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "drug_total_dose": 500,
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A",
    "patient_ID": "TCGA.GR.A4D4",
    "bcr_drug_barcode": "TCGA-GR-A4D4-D39068_2",
    "bcr_drug_uuid": "C661195A-490A-43E3-B08F-1243B337BA6B",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 94,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A",
    "patient_ID": "TCGA.GR.A4D4",
    "bcr_drug_barcode": "TCGA-GR-A4D4-D39068_4",
    "bcr_drug_uuid": "7D8AD5EC-085D-414A-96FA-2E40C83D4103",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "drug_total_dose": 500,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A",
    "patient_ID": "TCGA.GR.A4D4",
    "bcr_drug_barcode": "TCGA-GR-A4D4-D39068",
    "bcr_drug_uuid": "EFA6E2D3-4056-42F7-881D-3C3B2489100B",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 1403,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A",
    "patient_ID": "TCGA.GR.A4D4",
    "bcr_drug_barcode": "TCGA-GR-A4D4-D39068_3",
    "bcr_drug_uuid": "9813C8CB-BCE4-4AEF-B29F-E30C5F6879F8",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 5,
    "drug_total_dose": 2,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7DF78B5-24F1-4FF4-BD9B-F0E6BEC8289A",
    "patient_ID": "TCGA.GR.A4D4",
    "bcr_drug_barcode": "TCGA-GR-A4D4-D39068_5",
    "bcr_drug_uuid": "310BA478-3DC5-4696-B753-E8910A1AD68E",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 700,
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F855DAD1-6FFC-493E-BA6C-970874BC9210",
    "patient_ID": "TCGA.GR.A4D5",
    "bcr_drug_barcode": "TCGA-GR-A4D5-D39031_2",
    "bcr_drug_uuid": "BDDB2FD8-C033-4EA9-9921-585563E0F0EA",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 106,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F855DAD1-6FFC-493E-BA6C-970874BC9210",
    "patient_ID": "TCGA.GR.A4D5",
    "bcr_drug_barcode": "TCGA-GR-A4D5-D39031_3",
    "bcr_drug_uuid": "0631D13E-0C92-45E0-9295-27C24F9D5765",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 2,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F855DAD1-6FFC-493E-BA6C-970874BC9210",
    "patient_ID": "TCGA.GR.A4D5",
    "bcr_drug_barcode": "TCGA-GR-A4D5-D39031",
    "bcr_drug_uuid": "792ABD4D-6C23-4BB5-82E9-B971F770E203",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 1600,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F855DAD1-6FFC-493E-BA6C-970874BC9210",
    "patient_ID": "TCGA.GR.A4D5",
    "bcr_drug_barcode": "TCGA-GR-A4D5-D39031_4",
    "bcr_drug_uuid": "3FFFADE7-360F-437E-B19B-02B3A991312F",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDISONE",
    "drug_cycles": 6,
    "drug_total_dose": 500,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F855DAD1-6FFC-493E-BA6C-970874BC9210",
    "patient_ID": "TCGA.GR.A4D5",
    "bcr_drug_barcode": "TCGA-GR-A4D5-D39031_5",
    "bcr_drug_uuid": "2CA51914-BC75-469A-822C-A08406AD0EC6",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 800,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1C06604-5AE2-4A53-B9C0-EB210D38E3F0",
    "patient_ID": "TCGA.GR.A4D6",
    "bcr_drug_barcode": "TCGA-GR-A4D6-D39036_2",
    "bcr_drug_uuid": "FDA219DA-C7EB-41E8-A694-13948C3FBCD3",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 76,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1C06604-5AE2-4A53-B9C0-EB210D38E3F0",
    "patient_ID": "TCGA.GR.A4D6",
    "bcr_drug_barcode": "TCGA-GR-A4D6-D39036_4",
    "bcr_drug_uuid": "A0C75D5C-4EC9-4697-927B-6E31CE948C90",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "drug_total_dose": 500,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1C06604-5AE2-4A53-B9C0-EB210D38E3F0",
    "patient_ID": "TCGA.GR.A4D6",
    "bcr_drug_barcode": "TCGA-GR-A4D6-D39036_3",
    "bcr_drug_uuid": "8F182FF3-76BE-4AB2-B6FC-F0EBB94F1BE0",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 2,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1C06604-5AE2-4A53-B9C0-EB210D38E3F0",
    "patient_ID": "TCGA.GR.A4D6",
    "bcr_drug_barcode": "TCGA-GR-A4D6-D39036_5",
    "bcr_drug_uuid": "A447B596-6F48-4E3A-9D02-EE1BA39C8F92",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 566,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1C06604-5AE2-4A53-B9C0-EB210D38E3F0",
    "patient_ID": "TCGA.GR.A4D6",
    "bcr_drug_barcode": "TCGA-GR-A4D6-D39036",
    "bcr_drug_uuid": "C7CAE5D2-D331-47CA-8852-FEF360834F93",
    "form_completion_date": "2013-1-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 1133,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075_3",
    "bcr_drug_uuid": "4962F405-E230-4359-8C77-FCF035D99405",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "drug_cycles": 6,
    "drug_total_dose": 2,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075_6",
    "bcr_drug_uuid": "1319A53A-C5ED-41F1-8AC1-7E69FAAC8130",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "INTRATHECAL METHOTREXATE",
    "drug_cycles": 1,
    "drug_total_dose": 12,
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075_4",
    "bcr_drug_uuid": "085695DA-4DCE-48F0-828D-A0A88F062565",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "drug_cycles": 6,
    "drug_total_dose": 500,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075_5",
    "bcr_drug_uuid": "EDD1833E-D9C8-4635-85A4-F650CD5A9019",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "drug_total_dose": 758,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075_2",
    "bcr_drug_uuid": "B01818A8-20D6-4D3A-A32D-63AF77B506BE",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "drug_cycles": 6,
    "drug_total_dose": 100,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EFF68FF-F6C3-40C9-9FC8-00E684A7B712",
    "patient_ID": "TCGA.GR.A4D9",
    "bcr_drug_barcode": "TCGA-GR-A4D9-D39075",
    "bcr_drug_uuid": "99F7D111-5D1A-4B96-B4D8-AA4599F486C4",
    "form_completion_date": "2013-1-10",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "drug_cycles": 6,
    "drug_total_dose": 1516,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45B0CF9F-A879-417F-8F39-7770552252C0",
    "patient_ID": "TCGA.GS.A9TQ",
    "bcr_drug_barcode": "TCGA-GS-A9TQ-D66831",
    "bcr_drug_uuid": "7D872F80-BBFE-43C4-8404-CC4E518482B4",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45B0CF9F-A879-417F-8F39-7770552252C0",
    "patient_ID": "TCGA.GS.A9TQ",
    "bcr_drug_barcode": "TCGA-GS-A9TQ-D66831_2",
    "bcr_drug_uuid": "D1739790-8787-4B60-AFE2-1B2CA5D0CD0C",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45B0CF9F-A879-417F-8F39-7770552252C0",
    "patient_ID": "TCGA.GS.A9TQ",
    "bcr_drug_barcode": "TCGA-GS-A9TQ-D66831_3",
    "bcr_drug_uuid": "5BD6D8CF-23A8-474E-A37A-E9D5E407152C",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45B0CF9F-A879-417F-8F39-7770552252C0",
    "patient_ID": "TCGA.GS.A9TQ",
    "bcr_drug_barcode": "TCGA-GS-A9TQ-D66831_4",
    "bcr_drug_uuid": "60EEF95C-E8AA-429D-B1C2-E4149AB90E26",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45B0CF9F-A879-417F-8F39-7770552252C0",
    "patient_ID": "TCGA.GS.A9TQ",
    "bcr_drug_barcode": "TCGA-GS-A9TQ-D66831_5",
    "bcr_drug_uuid": "05587524-F07B-40FC-ADE5-0C14E8DCD572",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927_2",
    "bcr_drug_uuid": "3502D0DA-8E58-4AE1-A94C-BA5C43CA395E",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927_5",
    "bcr_drug_uuid": "438F32B2-E45A-48CB-AE07-2F56B6261843",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927_4",
    "bcr_drug_uuid": "99383D30-1894-43F0-A4B2-45041AA59DED",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927_3",
    "bcr_drug_uuid": "E39735C5-0B98-49D1-82B4-969DFCC33F9E",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927",
    "bcr_drug_uuid": "5495EA1E-398A-44DC-A9FE-A8F6A8894EDC",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33365D22-CB83-4D8E-A2D1-06B675F75F6E",
    "patient_ID": "TCGA.GS.A9TT",
    "bcr_drug_barcode": "TCGA-GS-A9TT-D66927_6",
    "bcr_drug_uuid": "AE2617A1-89DB-4AF1-9A1E-1708A5FFAF38",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "INTRATHECAL METHOTREXATE",
    "drug_cycles": 6,
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1EA575F1-F731-408B-A629-F5F4ABAB569E",
    "patient_ID": "TCGA.GS.A9TU",
    "bcr_drug_barcode": "TCGA-GS-A9TU-D66928_2",
    "bcr_drug_uuid": "6D355A41-66B3-4034-B3B3-EE80BF354B5A",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1EA575F1-F731-408B-A629-F5F4ABAB569E",
    "patient_ID": "TCGA.GS.A9TU",
    "bcr_drug_barcode": "TCGA-GS-A9TU-D66928_4",
    "bcr_drug_uuid": "F581CDB9-0C7C-4D18-B325-E195D01C4599",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1EA575F1-F731-408B-A629-F5F4ABAB569E",
    "patient_ID": "TCGA.GS.A9TU",
    "bcr_drug_barcode": "TCGA-GS-A9TU-D66928",
    "bcr_drug_uuid": "5E284FE8-D7FD-4A5C-AFDC-C94047F855E5",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1EA575F1-F731-408B-A629-F5F4ABAB569E",
    "patient_ID": "TCGA.GS.A9TU",
    "bcr_drug_barcode": "TCGA-GS-A9TU-D66928_5",
    "bcr_drug_uuid": "7D672389-386F-4DCF-BBB5-38D9CB4392B4",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1EA575F1-F731-408B-A629-F5F4ABAB569E",
    "patient_ID": "TCGA.GS.A9TU",
    "bcr_drug_barcode": "TCGA-GS-A9TU-D66928_3",
    "bcr_drug_uuid": "E8A31870-FE14-44BA-AF99-D1BE37DBB2E6",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85F340E-584B-4F3B-B6A5-540491FC8AD2",
    "patient_ID": "TCGA.GS.A9TV",
    "bcr_drug_barcode": "TCGA-GS-A9TV-D66930_4",
    "bcr_drug_uuid": "0AD68F98-9996-42A3-B9E8-A270BD73423F",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85F340E-584B-4F3B-B6A5-540491FC8AD2",
    "patient_ID": "TCGA.GS.A9TV",
    "bcr_drug_barcode": "TCGA-GS-A9TV-D66930_3",
    "bcr_drug_uuid": "AEAFE920-B76E-4AE8-8AC1-54D7C2434B04",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85F340E-584B-4F3B-B6A5-540491FC8AD2",
    "patient_ID": "TCGA.GS.A9TV",
    "bcr_drug_barcode": "TCGA-GS-A9TV-D66930",
    "bcr_drug_uuid": "20585AA6-AC5D-4A52-8EC7-CA1065F8DA5F",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85F340E-584B-4F3B-B6A5-540491FC8AD2",
    "patient_ID": "TCGA.GS.A9TV",
    "bcr_drug_barcode": "TCGA-GS-A9TV-D66930_2",
    "bcr_drug_uuid": "41DF0F32-083F-4A67-B060-888EA748502D",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85F340E-584B-4F3B-B6A5-540491FC8AD2",
    "patient_ID": "TCGA.GS.A9TV",
    "bcr_drug_barcode": "TCGA-GS-A9TV-D66930_5",
    "bcr_drug_uuid": "EA3C75E6-3E7F-47E0-AFEF-743EC3EA6A8E",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29AFF186-C321-4FF9-B81B-105E27E620FF",
    "patient_ID": "TCGA.GS.A9TW",
    "bcr_drug_barcode": "TCGA-GS-A9TW-D66932",
    "bcr_drug_uuid": "A0B2B1A8-CA34-4531-815F-CB081405AE9D",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29AFF186-C321-4FF9-B81B-105E27E620FF",
    "patient_ID": "TCGA.GS.A9TW",
    "bcr_drug_barcode": "TCGA-GS-A9TW-D66932_2",
    "bcr_drug_uuid": "351AEA5A-881D-4545-BD25-AB2BD16C7608",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29AFF186-C321-4FF9-B81B-105E27E620FF",
    "patient_ID": "TCGA.GS.A9TW",
    "bcr_drug_barcode": "TCGA-GS-A9TW-D66932_5",
    "bcr_drug_uuid": "041A5C55-00AD-4585-87A3-B9A456CA297D",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29AFF186-C321-4FF9-B81B-105E27E620FF",
    "patient_ID": "TCGA.GS.A9TW",
    "bcr_drug_barcode": "TCGA-GS-A9TW-D66932_3",
    "bcr_drug_uuid": "EE7AFD13-B452-46F1-8C72-C5ACE34E6F0E",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29AFF186-C321-4FF9-B81B-105E27E620FF",
    "patient_ID": "TCGA.GS.A9TW",
    "bcr_drug_barcode": "TCGA-GS-A9TW-D66932_4",
    "bcr_drug_uuid": "1F2E52FF-3CA0-490F-A54B-8E9748605FCD",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58E66976-4507-4552-AC53-83A49A142DDE",
    "patient_ID": "TCGA.GS.A9TX",
    "bcr_drug_barcode": "TCGA-GS-A9TX-D66933_4",
    "bcr_drug_uuid": "18360767-3825-481B-9A2F-82A5C5076E2D",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58E66976-4507-4552-AC53-83A49A142DDE",
    "patient_ID": "TCGA.GS.A9TX",
    "bcr_drug_barcode": "TCGA-GS-A9TX-D66933_5",
    "bcr_drug_uuid": "FFCAD2FB-B659-4586-94D4-C6783325A442",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58E66976-4507-4552-AC53-83A49A142DDE",
    "patient_ID": "TCGA.GS.A9TX",
    "bcr_drug_barcode": "TCGA-GS-A9TX-D66933_2",
    "bcr_drug_uuid": "2EE050A9-6116-4383-81F2-469154040153",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58E66976-4507-4552-AC53-83A49A142DDE",
    "patient_ID": "TCGA.GS.A9TX",
    "bcr_drug_barcode": "TCGA-GS-A9TX-D66933_3",
    "bcr_drug_uuid": "2B430828-5191-43E0-8A3C-868379E3ED40",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58E66976-4507-4552-AC53-83A49A142DDE",
    "patient_ID": "TCGA.GS.A9TX",
    "bcr_drug_barcode": "TCGA-GS-A9TX-D66933",
    "bcr_drug_uuid": "EBAD8FBD-C6F6-4827-B95B-C7D4188E74D8",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E9437F0-A4ED-475C-AB0E-BF1431C70A90",
    "patient_ID": "TCGA.GS.A9TY",
    "bcr_drug_barcode": "TCGA-GS-A9TY-D67340_2",
    "bcr_drug_uuid": "CB66A70E-8FA0-4E21-A77A-9F7D590F2F91",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E9437F0-A4ED-475C-AB0E-BF1431C70A90",
    "patient_ID": "TCGA.GS.A9TY",
    "bcr_drug_barcode": "TCGA-GS-A9TY-D67340",
    "bcr_drug_uuid": "E96719DD-8E36-4A34-AD85-274394F6F728",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E9437F0-A4ED-475C-AB0E-BF1431C70A90",
    "patient_ID": "TCGA.GS.A9TY",
    "bcr_drug_barcode": "TCGA-GS-A9TY-D67340_3",
    "bcr_drug_uuid": "B5F558BB-AD40-436E-9F6D-1332D308406D",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E9437F0-A4ED-475C-AB0E-BF1431C70A90",
    "patient_ID": "TCGA.GS.A9TY",
    "bcr_drug_barcode": "TCGA-GS-A9TY-D67340_4",
    "bcr_drug_uuid": "EE54467C-4BCA-4C46-8A1F-5EC3391A71CA",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EDA9496E-BE80-4A13-BF06-89F0CC9E937F",
    "patient_ID": "TCGA.GS.A9TZ",
    "bcr_drug_barcode": "TCGA-GS-A9TZ-D67343_2",
    "bcr_drug_uuid": "2F05F91C-7949-44B9-86E7-A1F3BDC50075",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EDA9496E-BE80-4A13-BF06-89F0CC9E937F",
    "patient_ID": "TCGA.GS.A9TZ",
    "bcr_drug_barcode": "TCGA-GS-A9TZ-D67343_4",
    "bcr_drug_uuid": "2AC1D20C-EAD8-47FC-8144-F6EC056516CC",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EDA9496E-BE80-4A13-BF06-89F0CC9E937F",
    "patient_ID": "TCGA.GS.A9TZ",
    "bcr_drug_barcode": "TCGA-GS-A9TZ-D67343",
    "bcr_drug_uuid": "6AA11DD3-C7D6-417B-803F-13767837ACA4",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EDA9496E-BE80-4A13-BF06-89F0CC9E937F",
    "patient_ID": "TCGA.GS.A9TZ",
    "bcr_drug_barcode": "TCGA-GS-A9TZ-D67343_3",
    "bcr_drug_uuid": "C414B662-B773-449F-81BF-2AD1F33EDF01",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EDA9496E-BE80-4A13-BF06-89F0CC9E937F",
    "patient_ID": "TCGA.GS.A9TZ",
    "bcr_drug_barcode": "TCGA-GS-A9TZ-D67343_5",
    "bcr_drug_uuid": "E3A0A1B9-9A41-4B75-9DEB-BEF27C15F59C",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F",
    "patient_ID": "TCGA.GS.A9U3",
    "bcr_drug_barcode": "TCGA-GS-A9U3-D67345_3",
    "bcr_drug_uuid": "F42D4178-2DDB-488F-983C-D878F2735484",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F",
    "patient_ID": "TCGA.GS.A9U3",
    "bcr_drug_barcode": "TCGA-GS-A9U3-D67345",
    "bcr_drug_uuid": "01AB2E47-60A0-4BCA-9FB5-3C148363F7AA",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F",
    "patient_ID": "TCGA.GS.A9U3",
    "bcr_drug_barcode": "TCGA-GS-A9U3-D67345_4",
    "bcr_drug_uuid": "93BD48F4-92D1-4037-9EA2-89E932EC436B",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F",
    "patient_ID": "TCGA.GS.A9U3",
    "bcr_drug_barcode": "TCGA-GS-A9U3-D67345_2",
    "bcr_drug_uuid": "187081CC-93B9-4353-B696-5799BD344722",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDECB74F-AC4E-46B1-B23A-5F7FDE96EF9F",
    "patient_ID": "TCGA.GS.A9U3",
    "bcr_drug_barcode": "TCGA-GS-A9U3-D67345_5",
    "bcr_drug_uuid": "11268295-BA82-4163-99CD-7AD09C82D117",
    "form_completion_date": "2014-11-6",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 6,
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_6",
    "bcr_drug_uuid": "19F1D53D-4644-45E3-8A63-C47E54FAE65C",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_9",
    "bcr_drug_uuid": "402BEF3C-4375-472A-A2F7-40C4D3FA5CF9",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "METILPREDNISONA",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_3",
    "bcr_drug_uuid": "45608110-E2D5-4523-AEE2-7BA499E0A872",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "VINCRISTINA",
    "drug_cycles": 4,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_8",
    "bcr_drug_uuid": "CA19E5AE-DDF9-411F-90DC-E0FE4AA5195A",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CISPLATIM",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_10",
    "bcr_drug_uuid": "13EABA44-10E5-47A0-AFAA-C337AB0F3D4D",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347",
    "bcr_drug_uuid": "9C2182E6-9A8B-409B-93FB-3F5095494FB9",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "drug_cycles": 4,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_2",
    "bcr_drug_uuid": "4A5E5122-9BE2-4F1C-A8F7-62B143B94F62",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "CICLOFOSFAMIDA",
    "drug_cycles": 4,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_5",
    "bcr_drug_uuid": "6F0E9355-393F-4C1A-BA53-6B7EF0B9C53A",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "PREDNISONA",
    "drug_cycles": 4,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_7",
    "bcr_drug_uuid": "075D3DA2-23E4-462C-8020-A31E1676A9D7",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E251C03-BF86-4ED8-B45D-3CBC97160502",
    "patient_ID": "TCGA.GS.A9U4",
    "bcr_drug_barcode": "TCGA-GS-A9U4-D67347_4",
    "bcr_drug_uuid": "ACEA65A2-23DB-4048-911E-C26D91225D03",
    "form_completion_date": "2014-11-11",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharm_regimen": "CHOP-21 + RITUXIMAB",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINA",
    "drug_cycles": 4,
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "25FF86AF-BEB4-480C-B706-F3FE0306F7CF",
    "patient_ID": "TCGA.RQ.A68N",
    "bcr_drug_barcode": "TCGA-RQ-A68N-D64662",
    "bcr_drug_uuid": "6AD27C58-A03D-47A2-A92A-5DCE2F54C99B",
    "form_completion_date": "2014-9-9",
    "stem_cell_transplantation": false,
    "therapy_regimen": "PRIMARY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharm_regimen": "HIGH DOSE METHOTREXATE W/LEUCOVORIN",
    "pharmaceutical_therapy_drug_name": "HIGH DOSE METHOTREXATE W/ LEUCOVORIN",
    "drug_cycles": 5,
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  }
]
